Simple high-performance liquid chromatographic separation of oxazepam and its diastereoisomeric glucuronides in serum - Applications in a pharmacokinetic study in sheep

被引:9
作者
Mawa, R
Mis, D
Gagnieu, MC
Grancher, D
PetitRamel, M
Bressolle, F
Vallon, JJ
机构
[1] HOP EDOUARD HERRIOT,LAB BIOCHIM PHARMACOTOXICOL & ANAL TRACES,F-69437 LYON 03,FRANCE
[2] FAC PHARM,LAB CHIM ANALYT 3,F-69437 LYON 03,FRANCE
[3] ECOLE NATL VET,LAB NUTR,F-67280 MARCY LETOILE,FRANCE
[4] UNIV LYON 1,LAB CHIM ANALYT 2,F-69622 VILLEURBANNE,FRANCE
[5] HOP CAREMEAU,LAB PHARMACOCINET,F-30006 NIMES,FRANCE
[6] FAC PHARM MONTPELLIER,LAB PHARMACOCINET,F-34060 MONTPELLIER 01,FRANCE
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 677卷 / 02期
关键词
oxazepam; oxazepam glucuronide; benzodiazepines;
D O I
10.1016/0378-4347(95)00470-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This paper describes a highly specific and sensitive method for quantifying oxazepam and its diastereoisomeric glucuronides in serum. The method involves sample clean-up by solid-phase extraction on C-18 cartridge followed by quantitation on a reversed-phase HPLC column. Diazepam is used as internal standard. Extraction recovery from serum proved to be more than 86%. Precision, expressed as C.V., was in the range 1.2-9.5%. The limits of quantification were 40, 400, and 200 nmol/l for oxazepam, S-(+)- and R-(-)-glucuronides, respectively. This method was applied to the determination of oxazepam and its diastereoisomeric glucuronides in serum collected during a pharmacokinetic study performed in sheep after oral administration of racemic oxazepam. S-(+)/R-(-) ratios were measured all along the sampling time collection and the pharmacokinetic parameters were determined.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 9 条
[1]   ENDOTRACHEAL AND AEROSOL ADMINISTRATIONS OF CEFTAZIDIME IN PATIENTS WITH NOSOCOMIAL PNEUMONIA - PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY [J].
BRESSOLLE, F ;
DELACOUSSAYE, JE ;
AYOUB, R ;
FABRE, D ;
GOMENI, R ;
SAISSI, G ;
ELEDJAM, JJ ;
GALTIER, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1404-1411
[2]  
GOMENI C, 1987, 7TH P INT C MED INF, P507
[3]  
MAWA RV, 1995, ANAL LETT, V28, P1387
[4]  
RUELIUS HW, 1979, DRUG METAB DISPOS, V7, P40
[5]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE, AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (03) :309-312
[6]  
SISENWINE SF, 1982, DRUG METAB DISPOS, V10, P605
[7]  
TABURET AM, 1986, THERAPIE, V41, P1
[8]   DIRECT HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS AND PRELIMINARY PHARMACOKINETICS OF ENANTIOMERS OF OXAZEPAM AND TEMAZEPAM WITH THEIR CORRESPONDING GLUCURONIDE CONJUGATES [J].
VREE, TB ;
BAARS, AM ;
WUIS, EW .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1991, 13 (02) :83-90
[9]  
1994, US PHARM, V33, P1929